$2.157
+0.146 (+6.77%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de ATOS por análisis de gráficos similares
Alphio's ATOS stock price prediction model matches the current Atossa Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $2.16 (-0.05%). The 1-week path is $2.13 (-1.18%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Atossa Therapeutics Inc?
Atossa Therapeutics Inc is not a good buy right now due to its current price of $2.1568, which is significantly below its 52-week high of $14.85, indicating a steep decline of 82.84% over the past year. Furthermore, the RSI is at 37.449, suggesting the stock is nearing oversold territory but has not yet shown signs of a reversal. The forward P/E ratio is 7.0423, which may seem attractive, but the company is experiencing substantial losses with a net income of -$9,589,000 in Q1 2026 and a gross profit of $0 in Q4 2024. The main risk is the company's ongoing financial struggles, as evidenced by a current ratio of 4.92, which, while still above 1, shows declining liquidity compared to previous quarters.
ATOS cerró en $2.16 el Friday, tras subir +6.77%
Atossa Therapeutics Inc (ATOS) last closed at $2.1568, gaining +6.77%. These facts feed the 1-day and 1-week ATOS price prediction above.
Consenso de analistas
Atossa Therapeutics Inc (ATOS): 1 comprar, 0 mantener, 0 vender. Perspectiva: Strong Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Factores de la previsión
Los factores de la previsión de Atossa Therapeutics Inc (ATOS) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de ATOS, ordenadas por similitud.
Análisis de estacionalidad de ATOS
Historically the probability of a positive November return for ATOS is 45.45%. October offers the highest probability of a positive month at 52.94%, while January is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de ATOS
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Nov 2026 | $0.93 | $1.02 | $1.03 | -52.87% |
| Dec 2026 | $0.77 | $0.88 | $0.99 | -59.25% |
En 2026, se proyecta que Atossa Therapeutics Inc (ATOS) oscile entre $0.77 y $1.03.
Previsión mensual de Atossa Therapeutics Inc para 2026
En Nov de 2026, se proyecta que Atossa Therapeutics Inc promedie $1.02, con un mínimo de $0.93 y un máximo de $1.03.
En Dec de 2026, se proyecta que Atossa Therapeutics Inc promedie $0.88, con un mínimo de $0.77 y un máximo de $0.99.
Artículos relacionados
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.